In type 1 diabetes, various metabolic disturbances are frequently observed. Importantly, these may negatively affect individuals' long-term health outcomes. The use of probiotics has, in other populations, been beneficially associated with many of these risk factors. We, therefore, assessed the cross-sectional associations between the use of probiotics-containing food products or supplements and various health markers in a large population of individuals with type 1 diabetes.Included were 1039 individuals (mean age 46 ± 14 years, 45% men) with type 1 diabetes and without end-stage renal disease. Based on the entries in the diet questionnaire and the food record, participants were divided into those using (Probiotics yes ) and not using (Probiotics no ) probiotics-containing products. Various standard health markers, such as weight, waist circumference, blood pressure, blood lipids, and HbA 1c , were measured during the study visit.In all, 403 (39%) individuals reported using probiotics. Adjusted with potential confounders, the rate of overweight/ obesity, body mass index, and waist-to-hip ratio were higher in the Probiotics no group. Moreover, the odds of metabolic syndrome, and its waist, blood pressure, HDL-cholesterol, and triglyceride components were higher amongst those not using probiotics. In the normal-weight individuals, using probiotics was associated with significantly better glycaemic control.Using probiotics-containing food products or supplements may beneficially affect many of the traditional risk factors related to the diabetic complications. Randomized controlled trials are required to verify these observations.